Showing results (91-100 of 2,355) with videos related to
Sort By:
Pageof 236
Psychological Medicine|May 1, 1997
Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implicationsJ E Alpert, L A Uebelacker, N E McLean, et al.Journal of Clinical Psychopharmacology|August 10, 1999
Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorderM Fava, J F Rosenbaum, A R Kolsky, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 1, 1997
A cross-sectional study of private psychiatric practices under a single-payer health care systemK Anderson, A Catterson, M Gaudet, et al.Journal of Clinical Psychopharmacology|February 1, 1990
Adjunctive clonazepam for maintenance treatment of bipolar affective disorderG S Sachs, J F Rosenbaum, L JonesThe Journal of Clinical Psychiatry|September 1, 1986
Clonazepam blockade of spontaneous and CO2 inhalation-provoked panic in a patient with panic disorderA Beckett, S M Fishman, J F RosenbaumJournal of Clinical Psychopharmacology|October 8, 1997
Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study GroupJ F Rosenbaum, G Moroz, C L BowdenActa Psychiatrica Scandinavica|June 1, 1996
Recovery from depression: risk or reality?J Angst, D J Kupfer, J F RosenbaumPsychopharmacology|June 13, 2001
Tryptophan depletion in SSRI-recovered depressed outpatientsM K Spillmann, A J Van der Does, M A Rankin, et al.The Journal of Clinical Psychiatry|June 27, 1998
Dopaminergic agents and stimulants as antidepressant augmentation strategiesA A Nierenberg, D Dougherty, J F RosenbaumThe Psychiatric Clinics of North America|January 9, 2001
Docosahexanoic acid and omega-3 fatty acids in depressionD Mischoulon, M FavaPageof 236